Hypothalamic Amenorrhea
10
5
5
2
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
20.0%
2 terminated out of 10 trials
50.0%
-36.5% vs benchmark
10%
1 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (10)
Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea
The REgistry of Very Early Estrogen and AnovuLation
Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders
Body Fat as Determinant of Female Gonadal Dysfunction
Hypothalamic Amenorrhea as a Fertility Status Marker for Cardiovascular Health (ARCH)
Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate
Hormone Dynamics and Bone Mineral Density in Anorexia Nervosa v. Hypothalamic Amenorrhea
The Luveris In Vitro Fertilization Trial
Total Antioxidant Capacity Before and After HRT in Hypotalamic Amenorrhea
Detailed Clinical, Biochemical and Genetic Characterization in Gonadotropin-releasing Hormone (GnRH) Deficiency Disorders